What are the most common nursing diagnoses for an adult with chronic kidney disease stages 3‑5 presenting with fluid overload, hypertension, and electrolyte disturbances?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: November 4, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Top Nursing Diagnoses for Chronic Kidney Disease Stages 3-5

The three most critical nursing diagnoses for adults with advanced CKD presenting with fluid overload, hypertension, and electrolyte disturbances are: (1) Excess Fluid Volume, (2) Risk for Electrolyte Imbalance, and (3) Risk for Infection.

Primary Nursing Diagnoses

1. Excess Fluid Volume (100% prevalence)

This diagnosis appears universally in CKD patients stages 3-5 with fluid overload 1, 2. The pathophysiology stems from declining GFR below 60 mL/min per 1.73 m², which impairs the kidneys' ability to maintain fluid balance 3.

Key assessment parameters:

  • Monitor 24-hour urine output (should be ≥0.8-1 L/day in patients with normal renal function not on diuretics) 4
  • Daily weights and intake/output records
  • Signs of volume overload: peripheral edema, pulmonary congestion, jugular venous distension
  • Serum sodium concentrations (more commonly related to hydration status than sodium content in PN) 4

Critical interventions:

  • Fluid restriction tailored to residual kidney function and urine output
  • Loop diuretics for volume overload (thiazides become less effective as GFR declines) 5, 6
  • Sodium restriction to <5 g/day 7

2. Risk for Electrolyte Imbalance (96.8-100% prevalence)

This diagnosis is nearly universal in advanced CKD patients 1, 2. As GFR declines below 60 mL/min per 1.73 m², the prevalence of electrolyte complications rises significantly 3.

Specific electrolyte concerns:

  • Hyperkalemia: Most critical risk, particularly with ACE inhibitors/ARBs 8

    • Monitor serum potassium with awareness of measurement variability (diurnal/seasonal variation, plasma vs. serum samples) 8
    • Implement dietary potassium restriction, limiting bioavailable potassium sources (especially processed foods) 8
    • Consider potassium binders when needed to avoid discontinuing cardio-renal protective medications 7
  • Metabolic acidosis: Serum bicarbonate monitoring essential 8

    • Consider pharmacological treatment when bicarbonate <18 mmol/L 8
    • Monitor to prevent bicarbonate exceeding upper normal limits 8
  • Phosphate/calcium imbalance: Bone disease complications begin at stage 3 3

3. Risk for Infection (100% prevalence)

Universal in hemodialysis patients due to vascular access and immunocompromised state 1, 2. This diagnosis reflects both the uremic environment and invasive procedures required for treatment.

Assessment focus:

  • Vascular access site monitoring (if applicable)
  • Signs of systemic infection in immunocompromised state
  • Uremic complications affecting immune function

Secondary High-Priority Diagnoses

4. Ineffective Health Management Related to Hypertension

Hypertension is both cause and complication of CKD and must be carefully controlled in all patients 3.

Blood pressure targets:

  • General CKD: <140/90 mmHg 5
  • Proteinuric CKD (>500 mg/24h or ACR >30 mg/mmol): <130/80 mmHg 5

Antihypertensive strategy for stages 3-5:

  • First-line: ACE inhibitors or ARBs for proteinuric disease 5
  • Add thiazide diuretics (loop diuretics if volume overload present) 5
  • Most patients require combination therapy 5
  • Critical caveat: Monitor for hyperkalemia and acute GFR decline with ACE inhibitors/ARBs; implement potassium management strategies rather than discontinuing these prognostically beneficial medications 8, 7

5. Imbalanced Nutrition: Less Than Body Requirements

Malnutrition risk increases significantly when GFR <60 mL/min per 1.73 m² 3.

Nursing interventions:

  • Registered dietitian nutritionist consultation is essential 9
  • Monitor appetite, dietary intake, body weight changes, anthropometric measurements 9
  • Assess for uremic symptoms affecting nutritional intake
  • Individualized meal planning addressing protein, phosphorus, potassium restrictions while preventing malnutrition 9

6. Risk for Decreased Cardiac Output

CVD events are more common than kidney failure in CKD patients 3. CKD is considered highest risk group for subsequent cardiovascular events 3.

Assessment priorities:

  • Left ventricular hypertrophy screening 3
  • Anemia evaluation (begins stage 3) 3
  • Volume status and blood pressure control

Clinical Action Plan by CKD Stage

Stage 3 (GFR 30-59 mL/min):

  • Begin evaluation and treatment of complications: anemia, malnutrition, bone disease 3
  • Intensify hypertension management
  • Nephrology consultation if complications cannot be adequately managed 3

Stage 4 (GFR 15-29 mL/min):

  • Mandatory nephrologist co-management (GFR <30 mL/min) 3
  • Preparation for kidney replacement therapy 3
  • Aggressive management of all complications

Stage 5 (GFR <15 mL/min):

  • Preparation for dialysis/transplantation 3
  • All previous interventions continue

Common Pitfalls to Avoid

  1. Discontinuing ACE inhibitors/ARBs prematurely due to hyperkalemia or mild GFR decline—instead, implement potassium management strategies 8, 7

  2. Using serum creatinine alone to assess kidney function—always calculate estimated GFR 10

  3. Inadequate fluid assessment—relying solely on clinical signs rather than systematic monitoring of weights, intake/output, and urine volume 4

  4. Late nephrology referral—associated with increased mortality; refer when GFR <30 mL/min 3

  5. Prescribing nephrotoxic medications (NSAIDs, certain antibiotics) without considering renal function 6

  6. Overlooking volume overload as cause of renal dysfunction—right heart failure and renal venous congestion can worsen kidney function 6

References

Research

Management of hypertension in chronic kidney disease.

Clinical medicine (London, England), 2026

Guideline

kdoqi clinical practice guideline for nutrition in ckd: 2020 update.

American Journal of Kidney Diseases, 2020

Guideline

meeting the challenges of the new k/doqi guidelines.

American Journal of Kidney Diseases, 2003

Related Questions

How should hypertension be managed in a patient with chronic kidney disease stage 2?
Can a patient who was initially normotensive develop hypertension after chronic kidney disease from another etiology, and how should this be evaluated?
What is the optimal management for uncontrolled severe hypertension in a 73‑year‑old woman with stage 3‑4 chronic kidney disease (severely reduced eGFR) who is already on irbesartan 150 mg daily, amlodipine 10 mg daily, carvedilol 12.5 mg twice daily, and has bradycardia?
In a 55-year-old man with uncontrolled hypertension and chronic kidney disease stage 2, which intervention most effectively delays progression to end‑stage renal disease?
How should a 50-year-old male with chronic kidney disease on hemodialysis, severe hypertension (blood pressure 220/100 mmHg) and uremic gastropathy presenting with hematemesis be managed?
What is the clinical significance of a reduced T3 uptake?
What is the appropriate workup and management for a 76-year-old patient presenting with bilateral dorsal and palmar hand numbness and tingling?
What are the principal types of cardiomyopathy?
Is venlafaxine an appropriate treatment for major depressive disorder in a 20‑year‑old adult?
In a patient with non‑occlusive iliac vein phlebitis who regularly runs and rides a mountain bike and is taking rivaroxaban, what precautions should be taken and should he continue using compression stockings?
What is the appropriate treatment for acute epididymo‑orchitis in an 80‑year‑old man?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.